Santen Pharmaceutical Co., Ltd. (4536.T)
JPY 1548.0
(-0.51%)
JPY 1548.0
(-0.51%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 72.64 Billion | 37.14 Billion | 46.04 Billion | 38.8 Billion | 39.94 Billion | 32.89 Billion |
| Net Income | 26.63 Billion | -14.98 Billion | 27.18 Billion | 6.64 Billion | 21.71 Billion | 31.94 Billion |
| Depreciation & Amortization | 18.17 Billion | 17.24 Billion | 17.05 Billion | 16.76 Billion | 16.57 Billion | 10.96 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 15.7 Billion | -5.05 Billion | 4.7 Billion | -21.47 Billion | -1.97 Billion | -6.31 Billion |
| Other non-cash items | 33.85 Billion | 39.94 Billion | -2.9 Billion | 36.87 Billion | 3.63 Billion | -3.7 Billion |
| Investing Cash Flow | -6.14 Billion | -26.77 Billion | -35.16 Billion | -53.35 Billion | -5.17 Billion | -2.93 Billion |
| Investments in PPE | -10.68 Billion | -24.58 Billion | -35.84 Billion | -23.8 Billion | -9.22 Billion | -8.33 Billion |
| Acquisitions | -207 Million | -3.47 Billion | -2.96 Billion | -29.18 Billion | -3.4 Billion | 1.47 Billion |
| Investment purchases | -508 Million | -589 Million | -1.06 Billion | -3.38 Billion | -398 Million | -931 Million |
| Sales/Maturities of investments | 4.12 Billion | 2.14 Billion | 3.87 Billion | 3.07 Billion | 3.5 Billion | 2.15 Billion |
| Other Investing Activities | 922 Million | -279 Million | 838 Million | -54 Million | 4.35 Billion | 2.69 Billion |
| Financing Cash Flow | -34.03 Billion | -37.22 Billion | 5.55 Billion | -16.68 Billion | -12.72 Billion | -28.1 Billion |
| Debt repayment | -2.11 Billion | -11.27 Billion | -20.46 Billion | -3 Billion | -500 Million | -4.09 Billion |
| Dividends payments | -11.88 Billion | -12.6 Billion | -11.99 Billion | -11.18 Billion | -10.37 Billion | -10.58 Billion |
| Common Stock Repurchased | -16.96 Billion | -26 Billion | -12 Million | - | -22 Million | -14.12 Billion |
| Common Stock Issuance | - | 12.22 Billion | -20.46 Billion | - | -1.38 Billion | 567 Million |
| Other Financing Activities | 217 Million | 445 Million | 58.48 Billion | -2.49 Billion | -446 Million | 128 Million |
| Accounts receivables | 18.38 Billion | -6.44 Billion | -1.96 Billion | -7.51 Billion | -3.05 Billion | -6.3 Billion |
| Accounts payables | -2.38 Billion | 3.68 Billion | 2.49 Billion | 4.94 Billion | 717 Million | 2.44 Billion |
| Inventory | -1.36 Billion | -1.14 Billion | 5.38 Billion | -4.59 Billion | -981 Million | -5 Billion |
| Other working capital | 1.06 Billion | -1.16 Billion | -1.2 Billion | -14.32 Billion | 1.34 Billion | 2.54 Billion |
| Cash at beginning of period | 57.9 Billion | 83.01 Billion | 62.88 Billion | 91.43 Billion | 70.79 Billion | 69.28 Billion |
| Cash at end of period | 94.58 Billion | 57.9 Billion | 83.01 Billion | 62.88 Billion | 91.43 Billion | 70.79 Billion |
| Capital Expenditure | -10.68 Billion | -24.58 Billion | -35.84 Billion | -23.8 Billion | -9.22 Billion | -8.33 Billion |
| Effect of forex changes on cash | 4.2 Billion | 1.73 Billion | 3.69 Billion | 2.69 Billion | -1.41 Billion | -338 Million |
| Net cash flow / Change in cash | 36.67 Billion | -25.11 Billion | 20.12 Billion | -28.54 Billion | 20.63 Billion | 1.51 Billion |
| Free Cash Flow | 61.96 Billion | 12.55 Billion | 10.2 Billion | 15 Billion | 30.71 Billion | 24.56 Billion |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.63 Billion | 30 Million | 26.63 Billion | 7.3 Billion | 8.86 Billion | 10.41 Billion |
| Depreciation & Amortization | 4.7 Billion | 4.56 Billion | 18.17 Billion | 4.68 Billion | 4.9 Billion | 4.03 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -2.69 Billion | 468 Million | 15.7 Billion | 15.74 Billion | 9.4 Billion | -10.59 Billion |
| Other non-cash items | -511 Million | 19.37 Billion | 33.85 Billion | 3.97 Billion | 2.01 Billion | -1.3 Billion |
| Investing Cash Flow | -1.01 Billion | -416 Million | -6.14 Billion | -1.94 Billion | -1.08 Billion | -2.7 Billion |
| Investments in PPE | -575 Million | -3.86 Billion | -10.68 Billion | -1.62 Billion | -2.25 Billion | -2.93 Billion |
| Acquisitions | - | - | -207 Million | -72 Million | 683 Million | -135 Million |
| Investment purchases | - | -8 Million | -508 Million | -287 Million | -6 Million | -456 Million |
| Sales/Maturities of investments | - | 3.35 Billion | 4.12 Billion | -248 Million | 380 Million | 388 Million |
| Other Investing Activities | -441 Million | 100 Million | 922 Million | 286 Million | 117 Million | 440 Million |
| Financing Cash Flow | -18.93 Billion | -2.71 Billion | -34.03 Billion | -11.65 Billion | -5.9 Billion | -13.76 Billion |
| Debt repayment | -764 Million | -1.79 Billion | -2.11 Billion | -102 Million | -216 Million | - |
| Dividends payments | -6.09 Billion | -89 Million | -11.88 Billion | -5.78 Billion | -88 Million | -5.92 Billion |
| Common Stock Repurchased | -12.07 Billion | - | -16.96 Billion | -5.18 Billion | -4.74 Billion | -7.03 Billion |
| Common Stock Issuance | - | - | - | - | 216 Million | - |
| Other Financing Activities | 1 Million | -1 Million | 217 Million | -590 Million | -1.07 Billion | -804 Million |
| Accounts receivables | 8.41 Billion | -4.96 Billion | 18.38 Billion | 8.3 Billion | 10.28 Billion | 4.76 Billion |
| Accounts payables | 1.52 Billion | -2.12 Billion | -2.38 Billion | 1.47 Billion | 2.17 Billion | -3.9 Billion |
| Inventory | -6.43 Billion | 4.98 Billion | -1.36 Billion | -1.58 Billion | -3.06 Billion | -1.7 Billion |
| Other working capital | -4.66 Billion | 871 Million | 1.06 Billion | 7.55 Billion | 14 Million | -9.75 Billion |
| Cash at beginning of period | 94.58 Billion | 82.03 Billion | 57.9 Billion | 64.72 Billion | 45.51 Billion | 57.9 Billion |
| Cash at end of period | 89.74 Billion | 94.58 Billion | 94.58 Billion | 82.03 Billion | 64.72 Billion | 45.51 Billion |
| Capital Expenditure | -575 Million | -3.86 Billion | -10.68 Billion | -1.62 Billion | -2.25 Billion | -2.93 Billion |
| Effect of forex changes on cash | 2.97 Billion | 2.46 Billion | 4.2 Billion | -802 Million | 1.01 Billion | 1.52 Billion |
| Net cash flow / Change in cash | -4.83 Billion | 12.55 Billion | 36.67 Billion | 17.3 Billion | 19.21 Billion | -12.39 Billion |
| Free Cash Flow | 11.56 Billion | 9.34 Billion | 61.96 Billion | 30.08 Billion | 22.93 Billion | -393 Million |
0JT5
688396
0688
MNTHF
ANORA
RETO